ATE328879T1 - Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv - Google Patents

Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv

Info

Publication number
ATE328879T1
ATE328879T1 AT02766142T AT02766142T ATE328879T1 AT E328879 T1 ATE328879 T1 AT E328879T1 AT 02766142 T AT02766142 T AT 02766142T AT 02766142 T AT02766142 T AT 02766142T AT E328879 T1 ATE328879 T1 AT E328879T1
Authority
AT
Austria
Prior art keywords
hiv
treatment
receptor antagonists
piperidine derivatives
ccr5 receptor
Prior art date
Application number
AT02766142T
Other languages
English (en)
Inventor
Anandan Palani
Michael W Miller
Jack D Scott
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE328879T1 publication Critical patent/ATE328879T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02766142T 2001-08-29 2002-08-28 Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv ATE328879T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31568301P 2001-08-29 2001-08-29

Publications (1)

Publication Number Publication Date
ATE328879T1 true ATE328879T1 (de) 2006-06-15

Family

ID=23225580

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02766142T ATE328879T1 (de) 2001-08-29 2002-08-28 Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv

Country Status (23)

Country Link
US (4) US20040010008A1 (de)
EP (1) EP1421075B1 (de)
JP (2) JP4223950B2 (de)
KR (1) KR20040029057A (de)
CN (1) CN1304389C (de)
AR (1) AR036366A1 (de)
AT (1) ATE328879T1 (de)
BR (1) BR0212108A (de)
CA (1) CA2457861A1 (de)
CY (1) CY1105198T1 (de)
DE (1) DE60212146T2 (de)
DK (1) DK1421075T3 (de)
EC (1) ECSP044993A (de)
ES (1) ES2264491T3 (de)
HU (1) HUP0402019A3 (de)
IL (1) IL160060A0 (de)
MX (1) MXPA04001886A (de)
NO (1) NO20041266L (de)
PL (1) PL368827A1 (de)
PT (1) PT1421075E (de)
RU (1) RU2004109510A (de)
WO (1) WO2003020716A1 (de)
ZA (1) ZA200401594B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108876D0 (en) * 2001-04-09 2001-05-30 Novartis Ag Organic Compounds
US7307090B2 (en) 2001-07-02 2007-12-11 Astrazeneca Ab Piperidine derivatives useful as modulators of chemokine receptor activity
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
GB0223223D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20040082612A1 (en) * 2002-10-15 2004-04-29 Baxter Ellen W Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
JP4757802B2 (ja) * 2003-11-03 2011-08-24 シェーリング コーポレイション ケモカインレセプターの阻害剤として有用なビピペリジニル誘導体
AU2004289690A1 (en) * 2003-11-10 2005-05-26 Schering Aktiengesellschaft Benzylether amine compounds useful as CCR-5 antagonists
WO2005101838A2 (en) 2004-04-13 2005-10-27 Incyte Corporation Piperazinylpiperidine derivatives as chemokine receptor antagonists
US7880002B2 (en) 2004-12-29 2011-02-01 Millennium Pharmaceuticals, Inc. Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
WO2006071958A1 (en) 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
EP1844037A1 (de) * 2005-01-20 2007-10-17 Pfizer Limited Chemische verbindungen
WO2006091534A1 (en) * 2005-02-23 2006-08-31 Schering Corporation Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
US20070010565A1 (en) * 2005-04-25 2007-01-11 Olaf Prien New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
EP2402316A1 (de) 2005-07-21 2012-01-04 AstraZeneca AB (Publ) Piperidinderivate
US8119661B2 (en) * 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
WO2009043747A2 (en) * 2007-10-01 2009-04-09 F. Hoffmann-La Roche Ag N-heterocyclic biaryl carboxamides as ccr receptor antagonists
JP5432249B2 (ja) 2008-06-18 2014-03-05 エフ．ホフマン−ラ ロシュ アーゲー 新規なヘテロアリールカルボキシアミド誘導体
GB201017345D0 (en) 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
JP2017501164A (ja) 2013-12-19 2017-01-12 バイエル ファーマ アクチエンゲゼルシャフト 置換されたピペリジニルテトラヒドロキノリン類
WO2015091420A1 (de) * 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
WO2015091415A1 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenorezeptor alpha 2c antagonisten
WO2015091414A2 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte piperidinyl-tetrahydrochinoline
EA037555B1 (ru) 2015-04-02 2021-04-13 Проксимэйджен, Элэлси Применение 6-{4-[1-(пропан-2-ил)пиперидин-4-ил]-1,4-диазепан-1-ил}-n-(пиридин-4-ил)пиридин-2-карбоксамида для лечения раковых заболеваний цнс
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
JP2024534781A (ja) 2021-08-18 2024-09-26 ケモセントリックス，インコーポレイティド Ｃｃｒ６阻害剤としてのアリールスルホニル（ヒドロキシ）ピペリジン

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
TW531537B (en) * 1995-12-27 2003-05-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
US5952349A (en) * 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
JP3068206B2 (ja) * 1996-07-10 2000-07-24 シェーリング コーポレイション ムスカリン様アンタゴニストとしての１，４―ジ―置換ピペリジン
EP1175402B1 (de) * 1999-05-04 2005-07-20 Schering Corporation Piperidinderivate verwendbar als ccr5 antagonisten
WO2001030348A1 (en) * 1999-10-25 2001-05-03 Janssen Pharmaceutica N.V. Use of substance p antagonists for influencing the circadian timing system
AR033517A1 (es) * 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0108876D0 (en) * 2001-04-09 2001-05-30 Novartis Ag Organic Compounds

Also Published As

Publication number Publication date
CN1551877A (zh) 2004-12-01
US20040092745A1 (en) 2004-05-13
PL368827A1 (en) 2005-04-04
HUP0402019A3 (en) 2009-07-28
BR0212108A (pt) 2004-08-24
IL160060A0 (en) 2004-06-20
ZA200401594B (en) 2004-11-24
CA2457861A1 (en) 2003-03-13
RU2004109510A (ru) 2005-10-20
ECSP044993A (es) 2004-04-28
DE60212146D1 (de) 2006-07-20
DK1421075T3 (da) 2006-09-18
ES2264491T3 (es) 2007-01-01
US8034933B2 (en) 2011-10-11
US7384948B2 (en) 2008-06-10
JP2008222722A (ja) 2008-09-25
EP1421075A1 (de) 2004-05-26
PT1421075E (pt) 2006-10-31
NO20041266L (no) 2004-03-26
AR036366A1 (es) 2004-09-01
KR20040029057A (ko) 2004-04-03
HK1061563A1 (en) 2004-09-24
JP4223950B2 (ja) 2009-02-12
HUP0402019A2 (hu) 2005-02-28
EP1421075B1 (de) 2006-06-07
JP2005502682A (ja) 2005-01-27
US20040010008A1 (en) 2004-01-15
CN1304389C (zh) 2007-03-14
DE60212146T2 (de) 2007-06-06
MXPA04001886A (es) 2004-06-15
US20080214575A1 (en) 2008-09-04
US20040092551A1 (en) 2004-05-13
WO2003020716A1 (en) 2003-03-13
CY1105198T1 (el) 2010-03-03
US7442703B2 (en) 2008-10-28

Similar Documents

Publication Publication Date Title
ATE328879T1 (de) Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv
DE60021371D1 (de) Piperidinderivate verwendbar als ccr5 antagonisten
NO20034311D0 (no) CCR5-antagonister for behandling av AIDS
ATE250605T1 (de) Piperidin verbindung zur behandlung von psoriasis
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
NO20050429D0 (no) Substituert kinolin-CCR5-reseptorantagonister
DE60231341D1 (de) Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
DE60318013D1 (de) N-oxid von n-phenyl-2-pyrimidinaminderivaten
DE60220661D1 (de) Transdermales pflaster zur verabreichung von fentanyl
DE60039446D1 (de) Cyclische aminverbindung als ccr5 antagonist
CH1175401H1 (de) Piperazin Derivate verwendbar als CCR5 Antagonisten
DE60224404D1 (de) Substiuierte piperidine als melanocortinrezeptor-modulatoren
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE371451T1 (de) Duale nk1/nk3 antagonisten zur behandlung von schizophrenie
ATE334965T1 (de) Piperidinverbindungen als muscarinantagonisten
ATE504293T1 (de) Substituierte carbostyrilderivate als 5-ht1a- subtyp agonisten zur behandlung von bipolarer störung
DE60208724D1 (de) Heteroaryl derivate als bessere liganden des nociceptinrezeptors orl-1
DE60221275D1 (de) Piperazin-derivate zur verwendung als ccr-3 rezeptor antagonisten zur behandlung von asthma
DE60313898D1 (de) Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
ATE282041T1 (de) Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
DE602004013427D1 (de) Biaryltetrahydroisochinolin-piperidine als selektive mch-rezeptor-antagonisten zur behandlung von adipositas und verwandten erkrankungen
NO20070878L (no) Dimere piperidinderivater
DE60330373D1 (de) Piperidinderivate als ccr5-inhibitoren
BR0317363A (pt) Antagonista de npy-5
DE602004006424D1 (de) Piperidinderivate als ccr5-rezeptormodulatoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1421075

Country of ref document: EP

REN Ceased due to non-payment of the annual fee